OXYGENTA PHARMACEUTICAL
Back to All Ratios
|
OXYGENTA PHARMACEUTICAL Last 5 Year Cash Earnings per Share (CEPS) History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| CEPS(Rs) | -2.40 | -0.24 | -6.70 | 0.69 | 4.04 |
What is the latest Cash Earnings per Share (CEPS) ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2025 | -2.40 |
| Mar2024 | -0.24 |
| Mar2023 | -6.70 |
| Mar2022 | 0.69 |
| Mar2021 | 4.04 |
How is Cash Earnings per Share (CEPS) of OXYGENTA PHARMACEUTICAL Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2025 | -2.4 | Negative | |
| Mar2024 | -0.24 | Negative | |
| Mar2023 | -6.7 | Negative | |
| Mar2022 | 0.69 | -82.92 | |
| Mar2021 | 4.04 | - | |
Other Financial Ratios of OXYGENTA PHARMACEUTICAL
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹206.4 Cr | 3.1% | -5.1% | -40.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,626.0 Cr | -1% | -4.9% | -7.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,758.0 Cr | -1.6% | -0.4% | 9.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹130,021.0 Cr | 0.2% | 2.8% | 12.2% | Stock Analytics | |
| CIPLA | ₹122,046.0 Cr | 1% | -0.9% | -1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,086.0 Cr | 0.4% | 0.9% | -8.9% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | 3.1% |
-5.1% |
-40.7% |
| SENSEX | -0.4% |
-0.6% |
8.6% |
You may also like the below Video Courses